Wha are the details?a
MTBC (Nasdaq:MTBC), a leading provider of proprietary, web-based electronic health records, practice management and mHealth solutions, today announced that its Board of Directors has approved the repurchase of up to $500,000 of the Company’s common stock. The plan runs for thirty days.
“This program reflects our Board of Directors’ and executive management team’s great confidence in MTBC’s growth prospects, long-term strategy and ability to generate long-term shareholder returns,” said Mahmud Haq, Chairman and Chief Executive Officer. “We are confident in the strength of our business and committed to building shareholder value as is evident through our repurchase program announcement today. Our stock price presents us with an exciting opportunity to purchase MTBC shares at attractive prices and return value to existing shareholders,” he added.
MTBC’s stock repurchase program allows MTBC to repurchase shares in open-market purchases in accordance with all applicable securities laws and regulations, including Rule 10b-18 of the Securities Exchange Act of 1934, as amended. Repurchases will depend upon a variety of factors, such as price, market conditions, volume limitations on purchases and other regulatory requirements, and other corporate considerations, as determined by MTBC’s management team. The repurchase program does not require the purchase of any minimum number of shares and may be modified, suspended or discontinued at any time. The Company will finance the stock repurchases with existing cash balances.
Medical Transcription Billing, Corp. is a healthcare information technology company that provides a fully integrated suite of proprietary web-based solutions, together with related business services, to healthcare providers practicing in ambulatory care settings. Our integrated Software-as-a-Service (or SaaS) platform helps our customers increase revenues, streamline workflows and make better business and clinical decisions, while reducing administrative burdens and operating costs.